Common Iliac Node-Positive Prostate Cancer Treated With Curative Radiation Therapy: N1 or M1a?
Pradnya Chopade(Homi Bhabha National Institute), Vedang Murthy(Homi Bhabha National Institute), Priyamvada Maitre(Homi Bhabha National Institute), Pallavi Singh, Reena Phurailatpam(Tata Memorial Hospital), Sam David(Homi Bhabha National Institute), Gitanjali Panigrahi(Homi Bhabha National Institute)
International Journal of Radiation Oncology*Biology*Physics
July 20, 2022
Cited by 16
Related Papers
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
|European Urology|2017|644
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
|European Urology|2020|396
Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis
|European Journal of Nuclear Medicine and Molecular Imaging|2011|377
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial
|Journal of Clinical Oncology|2017|340